A study of children with growth hormone deficiency from 14 countries measured their rate of growth for a year whilst being treated and mapped their response against the amount of summer daylight exp
Read more
It is important to involve patients and the public in pharmaceutical medicines research and development. Our Public Programmes team examine who is interested, who is not and why.
Read more
Michelle Baraclough is a researcher at NIHR Manchester Musculoskeletal Biomedical Research Unit. In this blog Michelle discusses her research into neurocognitive function in patients with lupus.
Read more
Researchers in Manchester have used recent advances in PET scanning technology to reduce the radiation dose for both patients and staff by up to 30%, allowing an addition of an annual 100 scans a year
Read more
A day of interactive and engaging activities to will help the public question, explore and share ideas on health data.
Read more
Susan has lupus, an autoimmune disease where the body mistakenly attacks health tissue. She has been a patient at MRI for almost 20 years and has taken part in a number of different research studies.
Read more
Our Consultants presented summaries of their team’s clinical and research expertise, patient populations in particular disease areas, and their aspirations relating to potential clinical trials.
Read more
The first few patients in London and Vancouver have received doses of an experimental RNA-targeting drug for Huntington’s disease, it was announced today.
Read more
